Kyoto, Japan

Hiroshi Kawamoto

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hiroshi Kawamoto: Innovator in Immunotherapy

Introduction

Hiroshi Kawamoto is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of immunotherapy, particularly through his innovative methods for inducing T cells from pluripotent stem cells. With a total of 4 patents, his work is paving the way for advancements in cell-based therapies.

Latest Patents

Kawamoto's latest patents include a method for inducing antigen-specific CD8 positive T cells. This method involves differentiating pluripotent stem cells to create a cell culture comprising CD4CD8T cells, followed by the removal of CD4CD8 cells and further differentiation into CD4CD8T cells. Another notable patent focuses on inducing T cells for cell-based immunotherapy, outlining a systematic approach to harnessing the potential of pluripotent stem cells for therapeutic applications.

Career Highlights

Throughout his career, Hiroshi Kawamoto has been associated with Kyoto University, where he has conducted extensive research in the field of immunology. His innovative approaches have garnered attention and recognition within the scientific community, contributing to the advancement of immunotherapy techniques.

Collaborations

Kawamoto has collaborated with notable colleagues such as Kyoko Masuda and Takuya Maeda. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his research.

Conclusion

Hiroshi Kawamoto's contributions to immunotherapy through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to inspire advancements in medical science and offers hope for future therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…